Compare ALGS & QUCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALGS | QUCY |
|---|---|---|
| Founded | 2018 | 2008 |
| Country | United States | Germany |
| Employees | N/A | 13 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.6M | 33.5M |
| IPO Year | 2020 | 2021 |
| Metric | ALGS | QUCY |
|---|---|---|
| Price | $5.59 | $1.46 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $39.33 | N/A |
| AVG Volume (30 Days) | 105.2K | ★ 643.5K |
| Earning Date | 05-05-2026 | 06-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 88.30 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,186,000.00 | N/A |
| Revenue This Year | $32.20 | $74.34 |
| Revenue Next Year | $4.71 | $171.48 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.98 | $0.30 |
| 52 Week High | $13.69 | $4.93 |
| Indicator | ALGS | QUCY |
|---|---|---|
| Relative Strength Index (RSI) | 56.92 | 52.82 |
| Support Level | $4.80 | $1.38 |
| Resistance Level | $5.94 | $2.36 |
| Average True Range (ATR) | 0.50 | 0.10 |
| MACD | 0.06 | 0.06 |
| Stochastic Oscillator | 84.07 | 67.31 |
Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.
Quantum Cyber NV is focused on building a diversified platform at the intersection of quantum computing and cybersecurity. It aims to secure critical infrastructure and data against these emerging threats.